07:00 , Apr 14, 2014 |  BC Week In Review  |  Clinical News

Piccolo Xpress regulatory update

Abaxis said Health Canada reclassified the company's blood chemistry analyzer Piccolo Xpress and Piccolo Reagent Discs as a Class III medical device from a Class II medical device. The reclassification allows for point-of-care diagnostic use...
07:00 , Sep 30, 2013 |  BC Week In Review  |  Company News

Abaxis management update

Abaxis Inc. (NASDAQ:ABAX), Union City, Calif.   Business: Supply/Service, Diagnostic, Veterinary   Resigned: Martin Mulroy as chief commercial officer, effective Oct. 4; COO Don Wood will assume Mulroy's responsibilities for leading Abaxis' North American Animal Health (NAAH)...
08:00 , Dec 17, 2012 |  BC Week In Review  |  Financial News

Abaxis financial update

Abaxis said its board declared a special cash dividend of $1 per share to be paid on Dec. 28 to shareholders of record as of Dec. 17. The company, which closed at $36.74 on Friday,...
07:00 , Oct 1, 2012 |  BC Week In Review  |  Company News

Abaxis, Cepheid diagnostic news

Abaxis and Cepheid settled a June 2010 patent suit filed in the U.S. District Court for the Northern District of California claiming that Cepheid's Xpert MRSA product infringed U.S. Patent Nos. 5,413,732; 5,624,597; 5,776,563;...
08:00 , Jan 25, 2010 |  BC Week In Review  |  Clinical News

C-Reactive Protein assay regulatory update

FDA granted 510(k) clearance for Abaxis' C-Reactive Protein (CRP) assay to detect inflammation or infection. Abaxis said the assay, which is used in conjunction with the Piccolo Xpress point-of-care blood test, can be used by...
07:00 , Sep 28, 2009 |  BioCentury  |  Politics, Policy & Law

The Counterattack

Even though the Senate Finance Committee will continue debating amendments to its healthcare reform legislation this week, much of the focus for pharmaceutical and biotech companies has already shifted to the next legislative inflection points...
00:42 , Sep 24, 2009 |  BC Extra  |  Politics & Policy

BayBio lobbying against PhRMA tax

BayBio, a trade association representing northern California life sciences companies, is lobbying Congress to reject proposed taxes on drug and medical device manufacturers and importers that are part of the healthcare legislation the Senate Finance...
08:00 , Dec 22, 2008 |  BC Week In Review  |  Clinical News

Piccolo Xpress regulatory update

FDA granted CLIA waiver for the Renal Function and MetLyte 8 panels to respectively measure phosphorous and creatine kinase when used in conjunction with Abaxis' Piccolo or Piccolo Xpress point-of-care blood tests. Abaxis Inc. (NASDAQ:ABAX),...
08:00 , Nov 3, 2008 |  BioCentury  |  Finance

Ebb & Flow

Cardiovascular and pulmonary company Dyax (NASDAQ: DYAX) has found a bevy of ways to bring in cash this year, despite the poor funding environment. Its latest move was to set up a $50 million committed...
08:00 , Dec 4, 2006 |  BC Week In Review  |  Company News

CytoCore board of directors update

CytoCore Inc. (CYCR), Chicago, Ill.   Business: Diagnostic   Appointed: Clint Severson, CEO of Abaxis Inc.   ...